Search filters

List of works by Naveena Singh

A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy.

scientific article published in June 2017

Artefactual punctate MLH1 staining can lead to erroneous reporting of isolated PMS2 loss

scientific article published on 12 July 2018

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

scientific article published on 12 October 2017

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

scientific article published on 27 February 2017

Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging

scientific article

High-grade serous carcinoma of tubo-ovarian origin: recent developments.

scientific article published on 06 May 2017

Interleukin-6 as a therapeutic target in human ovarian cancer

scientific article

Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871-879

scientific article published on 26 September 2020

Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results

scientific article published on 06 September 2019

Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances

scientific article published on 01 January 2020

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.

scientific article published in June 2016

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

scientific article published on 16 December 2015

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

scientific article published on 10 June 2019

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule

scientific article published on 3 December 2012

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

scientific article published on 11 May 2015

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

scientific article published on 11 March 2009

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

scientific article

The changing landscape of gynaecological pathology: WHO 2020 and beyond

scientific article published on 01 January 2020

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

scientific article published on 25 July 2017

Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma

scientific article published on 26 July 2019

Vulval squamous cell carcinoma and its precursors

scientific article published on 01 January 2020

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

scientific article published on 22 March 2023

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

scientific article published on 29 January 2020

Paulina is supported by:

About Paulina

Help